Pharmaceutical firm Bell-Kenz Pharma Inc. is turning the tables on those who accused the company of engaging in a “prescription for sale” scheme.

Kaha ʻia e ka Pākuʻi RSS ʻeā e Hoʻolālā CodeRevolution.